Clearside Biomedical Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 49 institutions reported holding Clearside Biomedical Inc. in their 13F filings, down 3 from Q1 2024. 6 opened new positions and 8 sold out. The largest holders were Vanguard Group Inc. ($3.7M), Rosalind Advisors, Inc. ($3.4M) and Armistice Capital, LLC ($2.8M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Clearside Biomedical Inc.
- CUSIP
- 185063104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $422K |
| Exits | 8 | $697K |
All 13F filers, Q1 2024 → Q2 2024: 914,434 shares bought and 2,646,636 shares sold, net −1,732,202 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 49 holders
| Vanguard Group Inc. | 0.00% | Add +14.0% | 2,839,978 | $3.7M |
| Rosalind Advisors, Inc. | 2.67% | No change | 2,592,593 | $3.4M |
| Armistice Capital, LLC | 0.07% | Reduce -46.0% | 2,136,000 | $2.8M |
| Carmignac Gestion | 0.05% | No change | 2,132,744 | $2.8M |
| BlackRock Inc. | 0.00% | Add +5.3% | 798,137 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +4.7% | 672,297 | $874K |
| Renaissance Technologies | 0.00% | Add +6.6% | 582,689 | $757K |
| Assenagon Asset Management S.A. | 0.00% | New | 283,193 | $368K |
| State Street Corp. | 0.00% | Add +6.1% | 205,163 | $267K |
| First Manhattan Co. Llc. | 0.00% | No change | 175,000 | $228K |
| Morgan Stanley | 0.00% | Reduce -4.6% | 145,990 | $190K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 133,451 | $173K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -0.1% | 130,000 | $169K |
| Brown Wealth Management, LLC | 0.05% | Reduce -9.1% | 100,000 | $130K |
| Citadel Advisors | 0.00% | Add +37.7% | 96,630 | $126K |
| Northeast Financial Consultants Inc | 0.01% | No change | 93,000 | $121K |
| Captrust Financial Advisors | 0.00% | Add +74.0% | 87,000 | $113K |
| Marshall Wace, LLP | 0.00% | Reduce -9.3% | 62,117 | $81K |
| XTX Topco Ltd | 0.01% | Add +172.2% | 54,313 | $71K |
| Synovus Financial Corp. | 0.00% | No change | 53,071 | $69K |
| Millennium Management | 0.00% | Reduce -79.3% | 42,889 | $56K |
| Banque Cantonale Vaudoise | 0.00% | No change | 40,000 | $52K |
| Prudential Financial Inc. | 0.00% | Add +75.3% | 35,400 | $46K |
| Stifel Financial Corp. | 0.00% | Reduce -21.8% | 30,544 | $40K |
| Jane Street Group, LLC | 0.00% | Reduce -83.8% | 28,693 | $37K |
| Curi Capital, LLC | 0.00% | No change | 25,000 | $33K |
| Squarepoint Ops LLC | 0.00% | New | 20,788 | $27K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 20,216 | $26K |
| International Assets Investment Management, LLC | 0.00% | Reduce -44.4% | 20,000 | $26K |
| Mariner, LLC | 0.00% | No change | 18,950 | $25K |
| Two Sigma Securities, LLC | 0.00% | Reduce -14.6% | 18,802 | $24K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +101.3% | 15,898 | $21K |
| Stratos Wealth Advisors, LLC | 0.00% | No change | 14,000 | $18K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Reduce -4.5% | 10,500 | $14K |
| JPMorgan Chase & Co. | 0.00% | Reduce -1.6% | 10,419 | $14K |
| Rockwood Wealth Management, LLC | 0.00% | New | 10,000 | $13K |
| Commonwealth Equity Services, LLC | 0.00% | New | 10,000 | $13K |
| Simplex Trading, LLC | 0.00% | Add +24.5% | 6,634 | $8K |
| Bank of America Corp. | 0.00% | Add +7.8% | 6,091 | $8K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 5,586 | $7K |
| Osaic Holdings, Inc. | 0.00% | Reduce -33.3% | 1,200 | $2K |
| Rhumbline Advisers | 0.00% | No change | 1,092 | $1K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 1,100 | $1K |
| Royal Bank of Canada | 0.00% | New | 568 | $1K |
| Russell Investments Group, Ltd. | 0.00% | New | 243 | $316 |
| Creative Financial Designs Inc. | 0.00% | No change | 100 | $130 |
| Wells Fargo & Company | 0.00% | Reduce -91.0% | 50 | $65 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -99.9% | 4 | $5 |
| BNP Paribas Financial Markets | 0.00% | No change | 2 | $3 |
"% of holder's portfolio" is CLEARSIDE BIOMEDICAL INC's weight in each manager's 13F, not the share of Clearside Biomedical Inc. the manager owns.